Company Filing History:
3 out of 469 
3 out of 987 
Years Active: 2005-2010
Title: Mark F Bear: Innovator in Neuropharmacology
Introduction
Mark F Bear is a prominent inventor based in Bristol, RI (US), known for his significant contributions to the field of neuropharmacology. He holds three patents that focus on innovative methods for treating various neurological disorders. His work has the potential to impact the lives of many individuals affected by these conditions.
Latest Patents
Among his latest patents, Bear has developed methods of treating disorders with Group I mGluR antagonists. Specifically, mGluR5 antagonists are utilized for the treatment and prevention of disorders such as Fragile X syndrome, autism, mental retardation, schizophrenia, and Down's Syndrome. These methods can also be applied to treat epilepsy and anxiety in individuals suffering from these disorders.
Career Highlights
Throughout his career, Mark F Bear has been associated with prestigious institutions, including Brown University and Emory University. His research has garnered attention for its innovative approach to addressing complex neurological issues.
Collaborations
Bear has collaborated with notable colleagues in his field, including Kimberly M Huber and Stephen T Warren. These partnerships have furthered the research and development of effective treatments for neurological disorders.
Conclusion
Mark F Bear's contributions to neuropharmacology through his patents and collaborations highlight his commitment to improving the lives of individuals with neurological disorders. His innovative methods continue to pave the way for advancements in treatment options.